(Q24236693)

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Safety and efficacy of single-dose fluconazole compared with a 7-day regimen of itraconazole in the treatment of AIDS-related oropharyngeal candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

A randomized clinical trial of chlorhexidine in the maintenance of oral candidiasis-free period in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Efficacy of alcohol-based and alcohol-free melaleuca oral solution for the treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Treatment of oral thrush in HIV/AIDS patients with lemon juice and lemon grass (Cymbopogon citratus) and gentian violet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Fluconazole therapy of oral candidiasis in HIV-infected patients: results of a multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

A randomized, double-blind, placebo-controlled study of itraconazole capsules for the prevention of deep fungal infections in immunodeficient patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Antifungal effect of mouth rinses on oral Candida counts and salivary flow in treatment-naïve HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Better reporting of randomised controlled trials: the CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Treatment of HIV-related fluconazole-resistant oral candidosis with D0870, a new triazole antifungal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Oropharyngeal candidiasis: a review of its clinical spectrum and current therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

The cost-effectiveness of preventing AIDS-related opportunistic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Prophylaxis for opportunistic infections in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

21 January 2018

Oral health & HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Oral manifestations of HIV infection. Definitions, diagnostic criteria, and principles of therapy. The U.S.A. Oral AIDS Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Oral lesions of HIV disease and HAART in industrialized countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Fluconazole-resistant Candida species in the oral flora of fluconazole-exposed HIV-positive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Anti-fungal therapy at the HAART of viral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Oral lesions in a group of Thai people with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Oral candidiasis and nutritional deficiencies in elderly hospitalised patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

In vitro and in vivo antifungal activities of D0870, a new triazole agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003940.PUB3

Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily.

21 January 2018

1 reference

12 December 2020

In vitro susceptibilities of Candida and Aspergillus species to Melaleuca alternafolia (tea tree) oil.

1 reference

12 December 2020

Interim proposal for a WHO Staging System for HIV infection and Disease

1 reference

12 December 2020

Oropharyngeal candidiasis: a new treatment option

1 reference

12 December 2020

Oral manifestations of HIV disease

1 reference

12 December 2020

Nystatin prophylaxis and treatment in severely immunodepressed patients

1 reference

12 December 2020

Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV

1 reference

12 December 2020

A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS

1 reference

12 December 2020

Effect of prolonged HAART on oral colonization with Candida and candidiasis

1 reference

12 December 2020

Single-dose versus 7 days of fluconazole treatment for oral candidiasis in human immunodeficiency virus-infected patients: a prospective, randomized pilot study

1 reference

12 December 2020

Fluconazole for oropharyngeal candidiasis in anti-HIV positive haemophiliacs

1 reference

12 December 2020

A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aureus carriage in the oral cavity

1 reference

12 December 2020

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

1 reference

12 December 2020

Oral manifestations of HIV infection in 600 South African patients.

1 reference

12 December 2020

Clinical trial: clotrimazole troche vs. itraconazole oral solution in the treatment of oral candidosis in AIDS patients

1 reference

12 December 2020

Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients.

1 reference

12 December 2020

1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA)

1 reference

12 December 2020

Classification and diagnostic criteria for oral lesions in HIV infection. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus

1 reference

12 December 2020

Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study

1 reference

12 December 2020

Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients

1 reference

12 December 2020

Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients

1 reference

12 December 2020

Taste and smell. Neglected senses that contribute to the malnutrition of AIDS

1 reference

12 December 2020

Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group

1 reference

12 December 2020

Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS

1 reference

12 December 2020

A dose comparison study of a new triazole antifungal (D0870) in HIV-positive patients with oral candidiasis

1 reference

12 December 2020

Fluconazole versus nystatin in the treatment of oral candidosis

1 reference

12 December 2020

HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro

1 reference

12 December 2020

Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV-infected patients. A double-blind placebo-controlled study

1 reference

12 December 2020

Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study Group

1 reference

12 December 2020

A comparison between fluconazole tablets and clotrimazole troches for the treatment of thrush in HIV infection

1 reference

12 December 2020

Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility

1 reference

12 December 2020

Fluconazole vs. Flucytosine in the Treatment of Esophageal Candidiasis in AIDS Patients: A Double-Blind, Placebo-Controlled Study

1 reference

12 December 2020

A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS

1 reference

12 December 2020

Classification, diagnostic criteria, and treatment recommendations for orofacial manifestations in HIV-infected pediatric patients. Collaborative Workgroup on Oral Manifestations of Pediatric HIV Infection

1 reference

12 December 2020

Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study

1 reference

12 December 2020

Oropharyngeal candidiasis in AIDS patients from Abidjan (Ivory Coast): antifungal susceptibilities and multilocus enzyme electrophoresis analysis of Candida albicans isolates.

1 reference

12 December 2020

Prophylaxis with nystatin pastilles for HIV-associated oral candidiasis

1 reference

12 December 2020

Oral lesions in infection with human immunodeficiency virus

1 reference

12 December 2020

Pharmacokinetics of two multiple-dosing regimens of D0870 in human immunodeficiency virus-positive patients: a phase I study

1 reference

12 December 2020

Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients

1 reference

12 December 2020

Treatment of oral candidiasis: a study to determine the clinical response of sodium benzoate compared with nystatin suspension

1 reference

12 December 2020

Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy

1 reference

12 December 2020